Help us learn about an investigational Staph Aureus vaccine.
Staph Aureus Vaccine
STAPH AUREUS VACCINE
STUDY INFORMATION
MedPharmics is now enrolling for an investigational vaccine that may provide protection against skin and soft tissue infections caused by Staphylococcus aureus. This bacteria has the highest antibiotic resistance and currently, no vaccine is available on the market. You may be eligible to participate in this study if you are 18 to 64 years old with a recent Staphylococcus aureus skin and soft tissue infection.
MEDICAL CONDITION
A recent Staphylococcus aureus skin and soft tissue infection
GENDER
Any
COMPENSATION
Participants may be paid up to $800 for full completion of the study for time and travel
LOCATION
Metairie, LA / Gulfport, MS / Slidell, LA
ENROLLMENT
Active
AGE RANGE
18 – 64 years old
COMMITMENT
14 Months
NUMBER OF VISITS
8 visits and 3 phone calls